---
title: "Adial Pharmaceuticals Names Matt Davidson President and CEO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303456370.md"
description: "Adial Pharmaceuticals appointed Matt Davidson as President and CEO effective October 28, 2026. The company also named Julie Saiki as Chief Strategy Officer, Celia Economides as CFO, David Rubenstein as Chief Scientist, and Ajay Duggal as Consulting Chief Medical Officer."
datetime: "2026-10-28T21:08:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303456370.md)
  - [en](https://longbridge.com/en/news/303456370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303456370.md)
generator: "portal-rs"
---

# Adial Pharmaceuticals Names Matt Davidson President and CEO

-   Adial Pharmaceuticals appointed former Verrica Pharmaceuticals CEO Matt Davidson president and CEO, effective October 28, 2026. \* Julie Saiki became chief strategy officer; she previously led Stanford’s Phase 1b ulcerative colitis study and consulted at McKinsey & Company. \* Celia Economides joined as chief financial officer, having most recently served as CellCentric’s chief financial and business officer. \* David Rubenstein became chief scientist; he previously served as Dermavant Sciences’ chief scientific officer, leading tapinarof development. \* Ajay Duggal was appointed consulting chief medical officer; he previously led Takeda’s general medicine therapeutic area as vice president. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-113337), on October 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [AZR.US](https://longbridge.com/en/quote/AZR.US.md)
- [TAK.US](https://longbridge.com/en/quote/TAK.US.md)
- [VRCA.US](https://longbridge.com/en/quote/VRCA.US.md)

## Related News & Research

- [Adial Pharmaceuticals Files Initial Beneficial Ownership Statement for CFO Vassiliki Economides](https://longbridge.com/en/news/303813186.md)
- [Adial Pharmaceuticals delays shareholder meeting vote on proposals 3-6 to Oct. 15 pending Nasdaq approval](https://longbridge.com/en/news/300824661.md)
- [Lumentum President and CEO Michael E. Hurlston Reports Disposal of $4.48 Million in Common Shares](https://longbridge.com/en/news/305879399.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [Marvell outlines custom HBM design approach at 2026 OCP Global Summit](https://longbridge.com/en/news/305857411.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**